Cyber security risk sparks implanted device recalls



Cyber security risk sparks implanted device recalls


Modern advances in digital health monitoring - including implantable sensors to detect irregular heartbeats, for example - are changing the way we manage our health.

These implanted devices are programmed wirelessly, and are able to transmit information to your doctor or to other devices, such as external blood sugar monitors which control how much insulin an implanted pump releases. 

However, it's unclear if the devices are safe from hackers who may be able to illegally access your information, steal your identity, or even make the implanted device malfunction. 

The FDA is warning that certain insulin pumps - the Medtronic MiniMed 508 series and MiniMed Paradigm series pumps - are at risk of being hacked. Medtronic recalled the mentioned pumps earlier this year, estimating that at least 4,000 people are at risk. The FDA stated that Medtronic would provide alternative pumps.

If you have one of the above devices, talk to your doctor to get the process started or if you are concerned that your pump's settings have been changed.

In March, the U.S. Department of Homeland Security issued similar warnings about 750,000 Medtronic implantable cardioverter-defibrillators. Medtronic did not recall them but is instead working on a software update in order to improve security.



In 1654, Rembrandt painted a picture of his mistress entitled “Bathsheba at her bath”. Over 300 years later, an Italian physician viewed the painting and noticed several characteristics of the left breast indicative of breast cancer. This title underlies James S. Olson’s book: Bathsheba’s breast: women, cancer & history, in which he examines breast cancer throughout history.

In 2019, an estimated 268,000 cases of invasive breast cancer will be diagnosed in women. But each year about 1 percent of all breast cancer cases will appear in men too — which works out to around 2,000 new cases. Male breast cancer is now more common than it was 25 years ago but a solemn fact remains: Experts simply don’t know the best way to treat breast cancer in men.

William G. Kaelin, MD, of Harvard University, Boston, Massachusetts, Gregg L. Semenza, MD, PhD, of Johns Hopkins University in Baltimore, Maryland, and Sir Peter J. Ratcliffe, FMedSci, of Oxford University in the United Kingdom have been awarded the 2019 Nobel Prize in Physiology or Medicine for their discoveries on how cells sense oxygen and adapt to it.

In its second edition, the International Journal of Disease Reversal and Prevention has published a breadth of new evidence suggesting among other things, that whole food plant-based nutrition may positively impact pulmonary hypertension, reverse type 2 diabetes, reverse blindness related to diabetic retinopathy and even improve sexual function in women.

The COMPLEMENTARY MEDICAL ASSOCIATION (The CMA) © 2012. No part of this site may be reproduced without the express permission of The Complementary Medical Association. If used without prior consent a charge of US $1,000 per article, or mini section is paid (US $50 per word (minimum) will be charged. This is not meant to reflect a commercial rate for the content, but as a punitive cost and to reimburse The CMA for legal fees and time costs). Use of the contents, without permission will be taken as consent to bill the illegal user in full.